Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Age-Related Macular Degeneration (AMD) Clinical Trials

8 recruiting trials for Age-Related Macular Degeneration (AMD). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
1
Phase 3 Trials
7
Sponsors

Recruiting Trials

RECRUITINGNCT07084883

Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular...

The purpose of this study is to perform a pivotal trial of iPredict, an automated AI-based system for early diagnosis and prediction of late AMD in primary care and ophthalmology...

Sponsor: iHealthScreen IncEnrolling: 10761 location
RECRUITINGNCT05932069

Active AMD Study to Improve Function in Veterans

Age Related Macular Degeneration (AMD) is the leading cause of vision loss among Veterans aged 50 years and older. AMD also adversely affects mortality, physical and cognitive...

Sponsor: VA Office of Research and DevelopmentEnrolling: 701 location
RECRUITINGPhase 3NCT06541704

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult...

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related...

Sponsor: Regeneron PharmaceuticalsEnrolling: 97520 locations
RECRUITINGNCT06843499

Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease...

This study aims to evaluate the effectiveness of an artificial intelligence (AI)-assisted screening system in ophthalmic diagnosis. Using AI-based fundus photography, the system...

Sponsor: National Taiwan University HospitalEnrolling: 10001 location
RECRUITINGPhase 4NCT07456826

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution...

This Phase 4, multicenter, randomized, double-masked clinical study evaluates the efficacy and safety of chloroprocaine hydrochloride ophthalmic gel 3% (IHEEZO) compared with...

Sponsor: Harrow IncEnrolling: 2361 location
RECRUITINGNCT07434713

EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open...

This prospective, observational, open-label study evaluates early treatment response to intravitreal aflibercept 8 mg in patients with exudative age-related macular degeneration....

Sponsor: Insel Gruppe AG, University Hospital BernEnrolling: 501 location
RECRUITINGNCT07069647

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in...

Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are leading causes of vision loss, with rising incidence due to aging populations and increasing diabetes...

Sponsor: National Taiwan University HospitalEnrolling: 43001 location
RECRUITINGNCT07500324

Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment

This prospective interventional translational study aims to identify and validate protein biomarkers associated with major ophthalmological diseases, including age-related macular...

Sponsor: Fondazione G.B. Bietti, IRCCSEnrolling: 2601 location